tetano
Editor, Senior Moderator
New Microbes New Infect
. 2020 Sep 22;100760.
doi: 10.1016/j.nmni.2020.100760. Online ahead of print.
What could explain the late emergence of COVID-19 in Africa?
Rym Lalaoui[SUP] 1 2 [/SUP], Sofiane Bakour[SUP] 1 2 [/SUP], Didier Raoult[SUP] 1 2 [/SUP], Pierre Verger[SUP] 2 3 4 [/SUP], Cheikh Sokhna[SUP] 2 4 [/SUP], Christian Devaux[SUP] 1 2 5 [/SUP], Bruno Pradines[SUP] 2 4 6 7 [/SUP], Jean-Marc Rolain[SUP] 1 2 [/SUP]
Affiliations
Abstract
At the end of November 2019, a novel coronavirus responsible for respiratory tract infections (COVID-19) emerged in China. Despite drastic containment measures, this virus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread in Asia and Europe. The pandemic is ongoing with particular hotspot in Southern Europe and America in Spring 2020. Many studies predicted a similar epidemic in Africa as that currently seen in Europe and the United States of America. However, reported data do not confirm these predictions. Several hypotheses that could explain the later emergence and spread of COVID-19 pandemic in African countries are being discussed, including the lack of health care infrastructure capable of clinically detecting and confirming COVID-19 cases, the implementation of social distancing and hygiene, international air traffic flows, the climate, the relatively young and rural population, the genetic polymorphism of the ACE2 receptor, cross-immunity and the use of antimalarial drugs.
Keywords: Africa; Antimalarial drugs; COVID-19; Malaria; SARS-CoV-2.
. 2020 Sep 22;100760.
doi: 10.1016/j.nmni.2020.100760. Online ahead of print.
What could explain the late emergence of COVID-19 in Africa?
Rym Lalaoui[SUP] 1 2 [/SUP], Sofiane Bakour[SUP] 1 2 [/SUP], Didier Raoult[SUP] 1 2 [/SUP], Pierre Verger[SUP] 2 3 4 [/SUP], Cheikh Sokhna[SUP] 2 4 [/SUP], Christian Devaux[SUP] 1 2 5 [/SUP], Bruno Pradines[SUP] 2 4 6 7 [/SUP], Jean-Marc Rolain[SUP] 1 2 [/SUP]
Affiliations
- PMID: 32983542
- PMCID: PMC7508045
- DOI: 10.1016/j.nmni.2020.100760
Abstract
At the end of November 2019, a novel coronavirus responsible for respiratory tract infections (COVID-19) emerged in China. Despite drastic containment measures, this virus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread in Asia and Europe. The pandemic is ongoing with particular hotspot in Southern Europe and America in Spring 2020. Many studies predicted a similar epidemic in Africa as that currently seen in Europe and the United States of America. However, reported data do not confirm these predictions. Several hypotheses that could explain the later emergence and spread of COVID-19 pandemic in African countries are being discussed, including the lack of health care infrastructure capable of clinically detecting and confirming COVID-19 cases, the implementation of social distancing and hygiene, international air traffic flows, the climate, the relatively young and rural population, the genetic polymorphism of the ACE2 receptor, cross-immunity and the use of antimalarial drugs.
Keywords: Africa; Antimalarial drugs; COVID-19; Malaria; SARS-CoV-2.